NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-7.48 Cr | ₹-21 Cr | ₹-2.80 Cr | ₹-12 Cr | ₹116 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NECTAR LIFESCIENCES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-7.48 Cr |
Mar2023 | ₹-21 Cr |
Mar2022 | ₹-2.80 Cr |
Mar2021 | ₹-12 Cr |
Mar2020 | ₹116 Cr |
How is Deferred Tax Assets / Liabilities of NECTAR LIFESCIENCES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-7.48 Cr | Negative | |
Mar2023 | ₹-21 Cr | Negative | |
Mar2022 | ₹-2.80 Cr | Negative | |
Mar2021 | ₹-12 Cr | Negative | |
Mar2020 | ₹116 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of NECTAR LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NECTAR LIFESCIENCES | ₹394.3 Cr | 1.4% | -16.8% | -37.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,712.0 Cr | -1.2% | 1.3% | 5.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,623.0 Cr | -2% | 1.3% | 45.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,285.0 Cr | 1.4% | 11.9% | 15.7% | Stock Analytics | |
CIPLA | ₹119,010.0 Cr | -0.6% | -2% | -1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,118.0 Cr | -1.2% | -6.7% | -8.4% | Stock Analytics |
NECTAR LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NECTAR LIFESCIENCES | 1.4% |
-16.8% |
-37.9% |
SENSEX | 0.1% |
1% |
2.6% |
You may also like the below Video Courses